1676-90-0

Basic information

• Product Name: Boc-L-aspartic acid 4-tert-butyl ester
• Synonyms: 4-tert-Butyl N-(tert-Butoxycarbonyl)-L-aspartate;N-(tert-Butoxycarbonyl)-L-aspartic Acid 4-tert-Butyl Ester 4-tert-Butyl N-Boc-L-aspartate N-Boc-L-aspartic Acid 4-tert-Butyl Ester Boc-Asp(OtBu)-OH;(2S)-4-tert-butoxy-2-[(tert-butoxycarbonyl)aMino]-4-oxobutanoic acid;N-Boc-L-aspartic acid 4-tert-butyl ester, 98%;N-tert-Butyloxycarbonyl-L-aspartic Acid β-tert-Butyl Ester;Boc-L-aspartic acid ?-tert-butyl ester99%;BOC-L-ASP(OTBU)-OH;BOC-L-ASP(TBU)-OH
• CAS NO: 1676-90-0
• Molecular Formula: C₁₃H₂₃NO₆
• Molecular Weight: 289.32
• Product Categories: Aspartic acid [Asp, D];Boc-Amino Acids and Derivative;Boc-Amino acid series
• Mol File: 1676-90-0.mol

Chemical Properties

• Melting Point: 64-67 °C
• Boiling Point: 432.6 °C at 760 mmHg
• Flash Point: 215.4 °C
• Appearance: White/Powder
• Density: 1.139 g/cm³
• Vapor Pressure: 1.07E-08mmHg at 25°C
• Refractive Index: 1.47
• Storage Temp.: 2-8°C
• Solubility: Soluble in methanol and dimethyl sulfoxide.
• PKA: 3.69±0.23(Predicted)
• BRN: 2336144
• CAS DataBase Reference: Boc-L-aspartic acid 4-tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Boc-L-aspartic acid 4-tert-butyl ester(1676-90-0)
• EPA Substance Registry System: Boc-L-aspartic acid 4-tert-butyl ester(1676-90-0)

Safety Data

• Safety Statements: 24/25
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 1676-90-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Boc-L-aspartic acid 4-tert-butyl ester is used as a building block for the synthesis of various pharmaceutical compounds, particularly those involving aspartic acid or its derivatives. Its presence in the molecule allows for the creation of novel drug candidates with potential therapeutic applications.
Used in Biochemistry Research:
In the field of biochemistry, Boc-L-aspartic acid 4-tert-butyl ester serves as a valuable research tool for studying the interactions and functions of aspartic acid in biological systems. Its unique structure enables researchers to investigate the role of aspartic acid in enzyme catalysis, protein folding, and other biochemical processes.
Used in the Preparation of Thrombin Inhibitors:
Boc-L-aspartic acid 4-tert-butyl ester is used as a key intermediate in the synthesis of highly selective thrombin inhibitors. Thrombin is an enzyme involved in the blood clotting process, and its inhibition can be beneficial in the treatment of conditions such as deep vein thrombosis and acute coronary syndrome.
Used in the Preparation of Thiopeptides:
The compound is also utilized in the preparation of thiopeptides, which are a class of naturally occurring peptides containing sulfur atoms. Thiopeptides possess potent antibiotic and anticancer properties, making them an important area of research in the development of new therapeutic agents.
Used in the Preparation of Thioacylating Agents:
Boc-L-aspartic acid 4-tert-butyl ester is employed in the synthesis of thioacylating agents, which are compounds that can transfer a thioacyl group to another molecule. These agents are valuable in organic chemistry and have applications in the modification of proteins, nucleic acids, and other biomolecules, as well as in the development of new drugs and pharmaceuticals.

InChI:InChI=1/C13H23NO6/c1-12(2,3)19-9(15)7-8(10(16)17)14-11(18)20-13(4,5)6/h8H,7H2,1-6H3,(H,14,18)(H,16,17)/t8-/m0/s1

Upstream product

• 1070-19-5 N-(tert-butyloxycarbonyl) azide 
• 146692-91-3 Z-aspartic acid alpha-tert-butyl ester 
• 3057-74-7 L-Asp(t-Bu) 
• 2673-19-0 4-tert-butyl 1-methyl L-aspartate hydrochloride 
• 16965-08-5 1,1-dimethylethyl 2,4,5-trichlorophenyl carbonate 
• 566188-97-4 Boc-Asp(OtBu)-OBn 
• 130074-09-8 Boc-Asp(OtBu)-OCet 
• 24424-99-5 di-tert-butyl dicarbonate 
• 30750-74-4 Boc-aspartic acid anhydride 
• 130052-01-6 α-2-cyanoethyl N(α)-tert-butoxycarbonyl-L-aspartate 
• 5545-52-8 Z-D(tBu)-OH 
• 2131-29-5 (S)-1-benzyl-4-tert-butyl 2-aminosuccinate 
• 36702-55-3 (S)-2-Benzyloxycarbonylamino-succinic acid 4-tert-butyl ester 1-ethyl ester 
• 1913-12-8 β-tert-butyl-N-(tert-butoxycarbonyl)-L-aspartic acid dicyclohexylammonium salt 

Downstream Products

• 1370749-25-9 tert-butyl N-[1-(2-hydroxyphenylcarbamoyl)-2-(tert-butoxycarbonyl)ethyl]carbamate 
• 1266116-37-3 3-tert-butoxycarbonylamino-4-[5-(trans-4-tert-butyl-cyclohexyloxy)-2,3-dihydro-indol-1-yl]-4-oxo-butyric acid tert-butyl ester 
• 1266120-58-4 3-tert-butoxycarbonylamino-4-[6-(4-tert-butyl-cyclohexyloxy)-3,4-dihydro-1H-isoquinolin-2-yl]-4-oxo-butyric acid tert-butyl ester 
• 115967-22-1 tert-butyloxycarbonyl-β-tert-butyloxyaspartyl-tyrosine α-methyl ester 
• 131368-08-6 tert-butoxycarbonyl-(β-tert-butyl)-L-aspartyl-L-phenylalanine thioamide 
• 92398-56-6 N-(tert-butyloxycarbonyl)-β-tert-butyl-L-aspartyl-D-α-aminobutyric acid benzyl ester 
• 92398-55-5 N-(tert-butyloxycarbonyl)-β-tert-butyl-L-aspartyl-D-alanine benzyl ester 
• 72594-93-5 α-<(benzyloxycarbonyl)hydrazidyl> β-tert-butyl tert-butyloxycarbonyl-L-aspartate 
• 92367-19-6 L-N-tert-butoxycarbonyl-β-tert-butylaspartyl-4'-(1-azi-2,2,2-trifluoroethyl)phenylalanine methyl ester 
• 139200-53-6 Boc-Asp(O^tBu)-OPac 
• 155541-33-6 (S)-N-Benzyl-3-tert-butoxycarbonylamino-N-ethoxycarbonylmethyl-succinamic acid tert-butyl ester 
• 155541-30-3 (S)-3-<(tert-butoxycarbonyl)amino>-N-cyclohexyl-N-<(ethoxycarbonyl)methyl>succinamic acid tert-butyl ester 
• 158306-72-0 Boc-Asp(OtBu)-Leu-Ala-Leu-OBzl 
• 184951-78-8 (S)-N-(2-Amino-5-nitro-phenyl)-3-tert-butoxycarbonylamino-succinamic acid tert-butyl ester 

Relevant articles and documents

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF

β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS

β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.

γ-Butyrobetaine hydroxylase catalyses a Stevens type rearrangement

γ-Butyrobetaine hydroxylase (BBOX) is a 2-oxoglutarate and Fe(II)-dependent oxygenase that catalyses the final step of l-carnitine biosynthesis in animals. BBOX catalyses the oxidation of 3-(2,2,2- trimethylhydrazinium)propionate (THP), a clinically used BBOX inhibitor, to form multiple products including 3-amino-4-(methyamino)butanoic acid (AMBA), which is proposed to be formed via a Stevens type rearrangement mechanism. We report the synthesis of AMBA and confirm that it is a product of the BBOX catalysed oxidation of THP. AMBA reacts with formaldehyde, which is produced enzymatically by BBOX, to give a cyclic adduct.

METHOD FOR THE SYNTHESIS OF PEPTIDES WITHOUT SOLVENT

The disclosure relates to a method for the synthesis of a compound of the formula (I) in which: n is an integer higher than or equal to 1; Rb and each Rn are independently a hydrogen atom, a C1-C6 arylalkyl group or a C1-C6 alkyl group substituted or not by an aryl group, —COOH, C1-C6, —COO-(alkyl), —CONH2, —SH, heteroaryl, —NH2, —NHC(NH)(NH2), C1-C6-s-(alkyl), —OH or phenol; Ra is a N-protective group; Rc is a ORd group in which Rd is a C1-C6 alkyl group or a NReRf group in which Re and Rf Re independently an N-protective group.

Chemokine receptor binding heterocyclic compounds

This invention relates to a novel class of heterocyclic compounds that bind chemokine receptors, inhibiting the binding of their natural ligands thereby. These compounds result in protective effects against infection by HIV through binding to chemokine receptors, including CXCR4 and CCR5, thus inhibiting the subsequent binding by these chemokines. The present invention provides a compound of Formula I wherein, W is a nitrogen atom and Y is absent or, W is a carbon atom and Y═H; R1to R7may be the same or different and are independently selected from hydrogen or straight, branched or cyclic C1-6alkyl; R8is a substituted heterocyclic group or a substituted aromatic group Ar is an aromatic or heteroaromatic ring each optionally substituted at single or multiple, non-linking positions with electron-donating or withdrawing groups; n and n′ are independently, 0-2; X is a group of the formula: Wherein, Ring A is an optionally substituted, saturated or unsaturated 5 or 6-membered ring, and P is an optionally substituted carbon atom, an optionally substituted nitrogen atom, sulfur or oxygen atom. Ring B is an optionally substituted 5 to 7-membered ring. Ring A and Ring B in the above formula can be connected to the group W from any position via the group V, wherein V is a chemical bond, a (CH2)n″group (where n″=0-2) or a C═O group. Z is, (1) a hydrogen atom, (2) an optionally substituted C1-6alkyl group, (3) a C0-6alkyl group substituted with an optionally substituted aromatic or heterocyclic group, (4) an optionally substituted C0-6alkylamino or C3-7cycloalkylamino group, (5) an optionally substituted carbonyl group or sulfonyl. These compounds further include any pharmaceutically acceptable acid addition salts and metal complexes thereof and any stereoisomeric forms and mixtures of stereoisomeric forms thereof.

WATER-SOLUBLE TRIAZOLE FUNGICIDE

A triazole compound of the general formula (I) or a pharmacologically acceptable salt thereof: [wherein,X represents a group of formula X-OH which has antifungal activity,L represents a -(adjacently substituted C6-C10 aryl)-CH2-group and the like, andR represents a -P(=O) (OH)2 group and the like.

An Effective Water-Free Aprotic System for Dissolving Free Amino Acids

An effective water-free system was proposed for dissolution and subsequent use in peptide synthesis of free amino acids and their derivatives. It consists of dimethylformamide, a tertiary base, and inorganic additives. Neutral salts (CF3COONa, Ba(ClO4)2, Ca(ClO4)2, NaClO4, BaI2, or Ca(NO3)2) serve as the inorganic additives that increase the solubility of free amino acids in dimethylformamide and provide true 0.2-3 M amino acid solutions. Triethylamine and N-methylmorpholine are most suitable as the tertiary bases. This system was used in reactions with acylating agents: Boc2O, ZOSu, FmocOSu, and activated derivatives of Nα-protected amino acids or peptides. The corresponding amino acid derivatives or Nα-protected di-, tri-, and tetrapeptides were obtained in yields of 80-99 percent at the reaction times of 30-240 min.

USE OF α-2-CYANOETHYL tert-BUTOXYCARBONYLASPARTATE AS AN INTERMEDIATE FOR SYNTHESIS OF β-ESTERS

The use of α-2-cyanoethyl Boc-aspartate is proposed for the first time for the synthesis of β-esters of Boc-aspartic acid.The α-2-cyanoethyl protective group is selectively split out by strong organic bases under hydrolytic conditions without the β-ester bond being affected.Using the α-2-cyanoethyl derivative, β-cyclohexyl, β-benzyl, and β-tert-butyl Boc-aspartates have been synthesized in good yields.